You are on page 1of 5


Abbasi A Muhammad, Hafeezullah, Nazir A Shah. Non High Density

Lipoprotein Cholesterolin Type 2 Diabetes Mellitus. Departement
Of Physiology and Pharmacology. Civil Hospital Of Khairpur.
Pakistan. 2007. 3 (2)
Aluni Juutilainen, Saara Kortelainen, Seppo Letto, et al. Gender
Difference in the Impact of Type 2 Diabetes on Coronary Heart
Disease Risk. American Diabetes Association. Diabetes Care.
Original Article. 2004. 27:2898-2409.
American Diabetes Association. Diagnosis and Classification of
Diabetes Melitus. Diabetes Care. Vol 36. Supp 1. 2013.
American Diabetes Association. Global Prevalence of Diabetes,
Estimates for the year 2000 and projections for 2030. Diabetes
Care. 2004:27.1047-1053
American Diabetes Association. Is Postprandial Glucose Control
Important In Primary Care Setting. Clinical Diabetes. Original
Article. 2010.
American Diabetes Association. Standart of Medical Care Diabetes Melitus Type 2.
Diabetes Care Vol 37. Supp 1. 2014.
American Diabetes Association. Standart Of Medical Care in
Diabetes. Diabetes Care. 2007:30:s4-s41
Anthony S Fauci, Eugene G, Dennis LK, et al. Harrisons Internal Medicine 17th ed.
New York: Mc Graw Hill Company. 2008.
Bantle JP, et al. Nutrition Recomendations and Interventions for Diabetes: a position
statement of the American Diabetes Association. Diabetes care 31., supplement
11., 2008. S61-S78
Brashers, VL. Aplikasi Klinis Patofisiologi: Pemeriksaan dan Manajemen. Kuncara
HY, editor; Yulianti, D., editor. Jakarta: EGC. 2009.hlm.1-7
Brunton, LL, Lazo SJ, Parker LK. Goodman & Gilmans The Pharmacological Basis
of Therapeutics, 11 th Edition, The McGraw-Hill Companies. 2007.
Centers for Disease Control and Prevention. Body Mass Index. Atlanta, GA: Centers
for Disease Control and Prevention, US Department of Health and Human
Services. 2011.
Centers for Disease Control and Prevention. Diabetes Report Card 2012. Atlanta,
GA: Centers for Disease Control and Prevention, US Department of Health and
Human Services. 2012.
Centers for Disease Control and Prevention. National Diabetes Fact Sheet, 2011.
Atlanta, GA: Centers for Disease Control and Prevention, US Department of
Health and Human Services. 2011.
Craig J Currie, Chris D Poole, Marc Evans, et al. Mortality and Other Important
Diabetes-Related Outcomes With Insulin vs Other Antihyperglycemic Therapies



in Type 2 Diabetes. Journal Of Clinical Endocrinology and Metabolism. Original

Article. J Clin Endocrinol Metab. 2013. 98(2):668-677.
Cy Pan, P Sinassammy et all. Insulin Glarigine versus NPH insulin therapy in Asian
type 2 Diabetes Patients. Elsevier. 2007.111-118.
Dahlan, MS., Besar Sampel dan Cara Pengambilan Sampel dalam Penelitian
Kedokteran dan Kesehatan. Jakarta: Salemba Medika. 2010.
David DAlessio. Irl B Hirsch. Glycemic Management Of Type 2 Diabetes. The
Endocrine Society. Translational Endocrinology & Metabolism. 2011
David M Nathan, John B Buse, Mayer B Davidson, et al. Medical
Management of Hyperglycemia in type 2 Diabetes: a consensus
statement of the American Diabetes Association and European
Association for the Study of Diabetes. American Diabetes
Association. Diabetes Care .2009.193-203
Davis TM, Davis Cylenne, Bruce DG. Glycaemic Levels Triggering Intensification
of Therapy in Type 2 Diabetes in Community : The Fremantle Diabetes
Study.Med J Aust. 2006. 184:325-328
website 2009. Diakses pada tanggal 1
januari 2014.
Eliza B Geer, Wei Shen. Gender Differences in Insulin Resistance.
Body Composition, and Energy. National Institute Of Health.
Supplemen 1. Gend Med . 2010.
Franco Cavalot, Andrea Pagliarino, Manuela Valle, et al. Postpradial Blood Glucose
Predicts Cardiovascular Events and All-Cause Mortality in Type 2 Diabetes in a
14-year follow-up. Diabetes Care. 2011. 34:2237-2243
Geltrude Mingrone, Simona Panunzi, Andrea G Gaetano, et al. Bariatric Surgery
versus Conventional Medical Therapy for Type 2 Diabetes. New England
Journal of Medicine. Original Article. 2012
Ginsberg HN, Zhang YL, Hernandez-Ono A. Regulation of Plasma Triglycerides in
Insulin Resistance and Diabetes. Arch Med Res 36:232240, 2005
Gregory AN, Teresa A Hillier, Jonathan B Brown. et al. Normal
Fasting Plasma Glucose and Risk Of Type 2 Diabetes Diagnosis.
American Journal Of Medicine. 2008. 515-524.
Gregory L Fucher, Jens S Christiansel, et al. Comparison of Insulin Degludec/Insulin
Aspart and Biphasic Insulin Aspart 30 in Uncontrolled, Insulin-Treated Type 2
Diabetes:A Phase 3a, Randomized, Treat-to-Target Trial. Diabetes Care. 2014.
Hachem SB, Mooradian. Familial Dyslipidaemias: an overview of genetics,
pathophysiology and management. 2006. 66:1949-1969
Harold E. Lebovitz. Insulin Potential Negative Consequences of Early
Routine Use In Patients With Type 2 Diabetes. American
Diabetes Association. Diabetes Care. 2011.
Hartono, Andry. Terapi Gizi dan Diet Rumah Sakit. Edisi 2. Jakarta ;EGC., 2012
Hauner H. Managing Type 2 Diabetes Melitus in Patients With
Obesity. Abstract. Treat Endocrinol. 2004;3(4):223-32.


Hillier TA, Pedula KL. Characteristics of an Adult Population with Newly Diagnosed
Type 2 Diabetes: The relation of obesity and age of onset. Diabetes Care. 2008.
Ina Danquah, George Addo, Karl J Terpe, et al. Diabetes Mellitus type 2 in Urban
Ghana: Characteristic and Associated Factors. Research Article. BioMed Central
Public Health. 2012. 12:210.
International Diabetes Federation. Global Guidline For type 2 Diabetes., Clinical
Guidelines Task Force. Belgium. 2012.
James H Anderson, Rocco L Brunelle, Veiko A Koivisto, et al.
Reduction of Postprandial Hyperglicaemia and Frequency of
Hypoglycaemia in IDDM Patients on Insulin-Analog Treatment.
American Diabetes Association.1997
Katzung, GB. Farmakologi Dasar dan Klinik. Edisi X. Editor, H.Azwar Agoes,
Jakarta : EGC. 2010
Kumar V, Cotran RS Robbins, et al. Buku Ajar Patologi. 7th ed Vol.2. Jakarta:
Penerbit Buku Kedokteran EGC. 2007.
Leo Niksanen, Lawrence A Letter, Edward Franek, et al. Comparison of a Soluble
Co-Formulation of Insulin Degludec/Insulin Aspart vs Biphasic Insulin Aspart
30 In Type 2 Diabetes: a Randomized Tiral. European Journal of Endocrinology.
European Society of Endocrinology. 2012. 287-294
Levene S, Donelly R. Management of Type 2 Diabetes Melitus A Practical Guide.
England. Butterworth Heinemann Elsevier. 2007.
Moonier L, Colette C, Percheron C, Descomps B. Insulin, Diabetes
and Cholesterol Metabolism. C R Seances Soc Bio Fil. Abstract.
Mooradian AD et al. Low Serum High-Density Lipoprotein Cholesterol in Obese
Subjects with Normal Serum Triglycerides: the role of insulin resistance and
inflammatory cytokines. Diabetes Obese Metab. 2007. 9:1152-1160
National Institute for Health and Clinical Excellence. Type 2
diabetes. The Management of Type 2 Diabetes. London. NICE
Clinical Guideline. 2008
Newman, WA. Kamus Kedokteran Dorland 29th. Editor : Huriawati, Hartanto, et all.
Jakarta: EGC. 2011.
Noor NN. Epidemiologi Konsep Penyebab Penyakit dan Hubungan Asosiasi.
Jakarta :Rineka Cipta. 2008., P. 26-54.
Paul A James, Suzane Oprail et al. 2014 Evidence-Based Guideline for the
Management of High Blood Pressure in Adults Report From The Panel Members
Appointed to the Eight Joint National Committee (JNC 8). American Medical
Association. 2014;311(5):507-520.
Perkumpulan Endokrinologi Indonesia. Konsensus Pengelolaan Diabetes Melitus di
Indonesia. Jakarta. PB PERKENI. 2011.
Persatuan Ahli Penyakit Dalam Indonesia. Buku Ajar Ilmu Penyakit Dalam. Edisi ke4. Pusat Penerbitan Departemen Ilmu Penyakit Dalam FKUI, Jakarta. 2006.
Peyrot M, Barnett A, Meneghini L, et all. Insulin adherence behaviours and barriers
in the multinational Global Attitudes of Patients and Physicians in Insulin
Therapy Study. Diabetic Medicine. 2012.


Peyrot M, Rubin RR, Lauritzen T, et al. Resistance to Insulin Therapy Among

Patients and Provides: Results of The Cross-National Diabetes Attitudes, Wishes
and Needs study The International DAWN Advisory Panel. American Diabetes
Association. Diabetes Care. 2005. 28:26732679
Powers AC, Fauci AS, Longo DL et al. Diabetes mellitus, In: Harrison's Principles of
Internal Medicine Eds. 17th edition. McGraw-Hill. New York. 2008: 2275-2279
Pradana S, John MF, Harsinen S. A Multicenter Prspective Non-Interventional
Evaluation of Efficacy and Safety of Using Biphasic Insulin Aspart as
Monotherapy, or in Combination with Oral Hypoglycemic Agent in Treatment of
Type 2 Diabetic Patients Before During and After Ramadhan Fasting in Routine
Clinical Practice., Maj Kedoteran Indon., 2009.
Pradana S, Laurentius A. Prevalence, Characteristic, and Predictors of Pre-Diabetes
in Indonesia. Med J Indones. 2011;20:283-94
Pradana S, Sidartawan S, Ketut S. The DiabCare Asia 2008 study : Outcomes On
Control And Complications of Type 2 Diabetic Patients in Indonesia. Journal Of
the Diab Care Asia Study. 2010.
Ram V Mahato, Prajwal Gyawali, Pramod Raud.. Association Between Glycaemic
Control and Serum Lipid Profile in Type 2 Diabetic patiens: Glycated
Hemoglobin as a Dual Biomarker. Institute Medicine of Katmandu. Nepal.
Bomedical Research. 2011. 22 (3):375-380.
Riset Kesehatan Dasar. 2007. Tersedia dalam website http://www.
laporanNasional%20Riskesdas%202007.pdf. diakses pada 11 December 2013.
Robert Turner. Intensive Blood-Glucose Control with Sulphonylureas or Insulin
Compared with Conventional Treatment and Risk of Complications in Patients
with Type 2 Diabetes UKPDS 33. United Kingdom Prospective Diabetes Study
Group. Lancet. 1998; 352:837-53.
Rury R Holman, Sanjoy K Paul, Angelyn Rethel. 10-Year Follow-up of Intensive
Glucose Control in Type 2 Diabetes. New England Journal of Medicine. Original
Article. 2008;359:1577-89.
Scott M Grundy, Gloria L Vega, et al. Efficacy, Safety and Tolerability of Once-Daily
Niacin for the Treatment of Dyslipidemia Associated with Type 2 DM. American
Medical Association. Arch Intern Med. 2002. 162:1568-1576.
Sidartawan S, Pradana S, Imam S, Penatalaksanaan Diabetes Melitus Terpadu 2 nd
edition. Balai Penerbit FKUI. Jakarta. 2009.
Silbernagl Stefan. Teks dan Atlas Berwarna Patofisiologi. Editor: Iwan Setiawan, et
all. Jakarta: EGC. 2007.
Song H Soon. Early-onset type 2 Diabetes Mellitus: a Condition With Elevated
Cardiovascular Risk. The British Journal Of Diabetes And Vascular Disease.
SAGE pub. 2008.8:61-5
Springer. Risk of Hypoglicaemia in Types 1 and 2 Diabetes:Effects of Treatment
Modalities and Their Duration. UK Hypoglicaemia Study Group. 2007.5:11401147
Steven M Haffner. Management Of Dyslipidemia In Adults With Diabetes.,
American Diabetes Association. Diabetes Care., 2003.21.160-178.
Wild S, Rolgic R, Green A, et al. Global Prevalence of Diabetes. Diab Care. 2004.,


William C Cushman, Gregory W Evans, Robert P Bryington, et al. Effect Intensive

Blood Pressure Control in Type 2 Diabetes Melitus. New England Journal of
Medicine. Original Article. 2010. 362:1575-85.
William Duckworth, Carlos Abraira, Thomas Morris, et al. Glucose Control and
Vascular Complications in Veterans with Type 2 Diabetes. New Englang Journal
of Medicine. Original Article. 2009.360:129-39
World Health Organisation. The Asia Pacific Perspective Redefining Obesity and its
Treatment. 2009. diakses pada
10 Januari 2014.
website 2014. Diakses pada 11 Maret